{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:11:53Z","timestamp":1778749913550,"version":"3.51.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prp.2026.156507","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:59:50Z","timestamp":1777359590000},"page":"156507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic targeting of lipid metabolism in cancer: Mechanisms, pathways, and translational prospects"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9135-0205","authenticated-orcid":false,"given":"Nazmun","family":"Lyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chowdhury Mobaswar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156507_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156507_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prp.2026.156507_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156507_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.prp.2026.156507_bib6","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.prp.2026.156507_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.prp.2026.156507_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/ijms16010924","article-title":"Lipid metabolism, apoptosis and cancer therapy","volume":"16","author":"Huang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/life12060784","article-title":"Lipid metabolism and cancer","volume":"12","author":"Cheng","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.prp.2026.156507_bib11","series-title":"Lipid Metabolism in Tumor Immunity, Adv. Exp. Med. Biol","first-page":"49","article-title":"Lipid metabolism in cancer cells","author":"Zheng","year":"2021"},{"key":"10.1016\/j.prp.2026.156507_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbcan.2018.07.002","article-title":"Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors","volume":"1870","author":"Samanta","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib13","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1172\/JCI84430","article-title":"Hypoxia-inducible factors: a central link between inflammation and cancer","volume":"126","author":"Triner","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2026.156507_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/molecules29020531","article-title":"CD36: The bridge between lipids and tumors","volume":"29","author":"Zhou","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156507_bib15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prp.2026.156507_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101178","article-title":"Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism","volume":"87","author":"Huang","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.prp.2026.156507_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib18","first-page":"358","article-title":"Increased lipogenesis in cancer cells: new players, novel targets","volume":"9","author":"Swinnen","year":"2006","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.prp.2026.156507_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","article-title":"De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0899-9007(99)00266-X","article-title":"Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology","volume":"16","author":"Kuhajda","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.prp.2026.156507_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-024-02426-0","article-title":"Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment","volume":"24","author":"Zhang","year":"2025","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prp.2026.156507_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10555-024-10170-1","article-title":"Lipid metabolism and its implications in tumor cell plasticity and drug resistance","volume":"43","author":"Vishwa","year":"2024","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.prp.2026.156507_bib23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1186\/s12885-024-13265-8","article-title":"Blood lipid metabolic biomarkers as prognostic indicators in cancer patients","volume":"24","author":"Peng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622908","article-title":"Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity?","volume":"9","author":"Vona","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.02.010","article-title":"Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer","volume":"86","author":"Wang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2026.156507_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.prp.2026.156507_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1614498","article-title":"Integrated analysis of single cell and spatial transcriptomics revealed a metastasis mechanism mediated by fatty acid metabolism in lymph nodes of head and neck cancer","volume":"16","author":"Weng","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2026.156507_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/metabo13070867","article-title":"Mass spectrometry detects sphingolipid metabolites for discovery of new strategy for cancer therapy from the aspect of programmed cell death","volume":"13","author":"Shi","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.prp.2026.156507_bib29","series-title":"Adv. Exp. Med. Biol","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-981-33-6785-2_4","article-title":"Lipid metabolism in cancer cells","author":"Zheng","year":"2021"},{"issue":"1","key":"10.1016\/j.prp.2026.156507_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7150\/jca.89338","article-title":"Interplay of sphingolipid metabolism in predicting prognosis of GBM patients: towards precision immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124795","article-title":"Spatial lipidomics and metabolomics of multicellular tumor spheroids using MALDI-2 and trapped ion mobility imaging","volume":"265","author":"Chen","year":"2023","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.prp.2026.156507_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2026.156507_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/biology9120434","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti","year":"2020","journal-title":"Biology"},{"issue":"7","key":"10.1016\/j.prp.2026.156507_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/1873-3468.70013","article-title":"Immunoregulatory mechanisms of the arachidonic acid pathway in cancer","volume":"599","author":"Tredicine","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2026.156507_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fphar.2020.01289","article-title":"Leukotrienes in tumor-associated inflammation","volume":"11","author":"Tian","year":"2020","journal-title":"Front. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156507_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1014-8","article-title":"Roles of sphingosine-1-phosphate signaling in cancer","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"9","key":"10.1016\/j.prp.2026.156507_bib38","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/nu13093202","article-title":"Ketogenic diets in pancreatic cancer and associated cachexia: cellular mechanisms and clinical perspectives","volume":"13","author":"Cortez","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.prp.2026.156507_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.medj.2021.12.008","article-title":"Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth","volume":"3","author":"Yang","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.prp.2026.156507_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1497461","article-title":"Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156507_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11154-020-09567-4","article-title":"Ketotherapy as an epigenetic modifier in cancer","volume":"21","author":"Bandera-Merchan","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.prp.2026.156507_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/nbu.12693","article-title":"Effects of ketogenic diets on cancer-related variables: A systematic review and meta-analysis of randomised controlled trials","volume":"49","author":"Salido-Bueno","year":"2024","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.prp.2026.156507_bib43","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/biom14111437","article-title":"Fasting as an adjuvant therapy for cancer: Mechanism of action and clinical practice","volume":"14","author":"Xie","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156507_bib44","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2023.05.008","article-title":"Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia","volume":"35","author":"Ferrer","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2026.156507_bib45","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/molecules25173935","article-title":"Fatty acid synthase: An emerging target in cancer","volume":"25","author":"Fhu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156507_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.it.2021.11.007","article-title":"The cholesterol pathway: impact on immunity and cancer","volume":"43","author":"King","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.prp.2026.156507_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41420-023-01493-z","article-title":"Lipid droplets: A cellular organelle vital in cancer cells","volume":"9","author":"Jin","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156507_bib48","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41418-023-01230-0","article-title":"Ionizing radiation-induced mitophagy promotes ferroptosis by increasing intracellular free fatty acids","volume":"30","author":"Yang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2026.156507_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/ph16060783","article-title":"NF-\u03baB in cell deaths, therapeutic resistance and nanotherapy of tumors: Recent advances","volume":"16","author":"Wu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156507_bib51","article-title":"Lipid metabolism involved in progression and drug resistance of breast cancer","volume":"12","author":"Fu","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.prp.2026.156507_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40364-024-00681-y","article-title":"Roles of posttranslational modifications in lipid metabolism and cancer progression","volume":"12","author":"Feng","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2026.156507_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodr\u00edguez","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib54","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/cancers16071313","article-title":"Targeting dysregulated lipid metabolism in cancer with pharmacological inhibitors","volume":"16","author":"Gupta","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib55","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fonc.2020.01185","article-title":"Inhibition of fatty acid synthase upregulates expression of CD36 to sustain proliferation of colorectal cancer cells","volume":"10","author":"Drury","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.prp.2026.156507_bib57","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"Med. Comm."},{"key":"10.1016\/j.prp.2026.156507_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41523-021-00324-7","article-title":"Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer","volume":"7","author":"Gyamfi","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","article-title":"Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches","volume":"14","author":"Navarro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156507_bib61","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.3390\/ijms26136013","article-title":"Targeting prostate cancer metabolism through transcriptional and epigenetic modulation: a multi-target approach to therapeutic innovation","volume":"26","author":"Espitia-P\u00e9rez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2022.100601","article-title":"Investigation of novel compounds via in silico approaches of EGFR inhibitors as anticancer agents","volume":"99","author":"T\u00fcrkmeno\u011flu","year":"2022","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.prp.2026.156507_bib63","first-page":"1","article-title":"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.prp.2026.156507_bib64","first-page":"1561","article-title":"Analysis of hypoxia-associated gene expression in prostate cancer: Lysyl oxidase and glucose transporter-1 expression correlate with Gleason score","volume":"20","author":"Stewart","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156507_bib65","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/cancers13102475","article-title":"The role of ceramide metabolism and signaling in the regulation of mitophagy and cancer therapy","volume":"13","author":"Sheridan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/cells9020337","article-title":"Sphingosine-1-phosphate in the tumor microenvironment: a signaling hub regulating cancer hallmarks","volume":"9","author":"Riboni","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156507_bib68","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/ijms26031056","article-title":"Sphingosine-1-phosphate metabolic pathway in cancer: implications for therapeutic targets","volume":"26","author":"Rufail","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib69","article-title":"The key role of sphingolipid metabolism in cancer: new therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/pharmaceutics15020437","article-title":"Lipid biomarkers in liquid biopsies: novel opportunities for cancer diagnosis","volume":"15","author":"Sagini","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156507_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166824","article-title":"Metastatic outgrowth via the two-way interplay of autophagy and metabolism","volume":"1870","author":"Behrooz","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.prp.2026.156507_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40104-025-01255-0","article-title":"LAPTM4B as a key regulator in the copper-induced endoplasmic reticulum\u2013lysosome interplay disorder in duck liver and the protective role of baicalin","volume":"16","author":"Shang","year":"2025","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.prp.2026.156507_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/10409238.2025.2521321","article-title":"ATG16L1 membrane recruitment in autophagy","volume":"60","author":"Wei","year":"2025","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib74","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.7150\/ijbs.105361","article-title":"Fatty acid trafficking between lipid droplets and mitochondria: An emerging perspective","volume":"21","author":"Smolkov\u00e1","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622908","article-title":"Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity","volume":"9","author":"Vona","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib76","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.3390\/cells11162562","article-title":"Modulating chaperone-mediated autophagy and its clinical applications in cancer","volume":"11","author":"Hubert","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156507_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41420-024-01958-9","article-title":"Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: Insights into apoptosis, autophagy, ferroptosis, and pyroptosis","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156507_bib78","article-title":"Cooperative application of transcriptomics and ceRNA hypothesis: lncRNA-00742\/miR-116 targets CD74 to mediate vanadium-induced mitochondrial apoptosis in duck liver","volume":"480","author":"Chen","year":"2024","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.prp.2026.156507_bib79","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3390\/cancers15082195","article-title":"Regulation of autophagy via carbohydrate and lipid metabolism in cancer","volume":"15","author":"Alizadeh","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib80","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fcell.2020.00431","article-title":"Interplay between lipid metabolism and autophagy","volume":"8","author":"Xie","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/cancers11050649","article-title":"Targeting ATG4 in cancer therapy","volume":"11","author":"Fu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189051","article-title":"Targeting lipid metabolism in cancer metastasis","volume":"1879","author":"Pascual","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib83","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2026.156507_bib84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.prp.2026.156507_bib85","article-title":"Signaling pathways in cancer metabolism: mechanisms and therapeutic targets","volume":"8","author":"You","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156507_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40169-018-0199-0","article-title":"Lipidomics: a promising cancer biomarker","volume":"7","author":"Yan","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.prp.2026.156507_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12944-024-02121-0","article-title":"Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies","volume":"23","author":"Takanashi","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prp.2026.156507_bib90","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/biom10101357","article-title":"Sphingolipid metabolism in glioblastoma and metastatic brain tumors: a review of sphingomyelinases and sphingosine-1-phosphate","volume":"10","author":"Hawkins","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156507_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70975","article-title":"Lipid metabolism in gastrointestinal malignancies: exploring dysregulation, biomarkers, and treatment strategies","volume":"14","author":"An","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2026.156507_bib92","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/medicina57070729","article-title":"Ceramide metabolism enzymes\u2014therapeutic targets against cancer","volume":"57","author":"Gomez-Larrauri","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.prp.2026.156507_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1519592","article-title":"Rewiring lipid metabolism to enhance immunotherapy efficacy in melanoma: a frontier in cancer treatment","volume":"15","author":"Xiong","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib94","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-024-02426-0","article-title":"Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment","volume":"24","author":"Zhang","year":"2025","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prp.2026.156507_bib95","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib96","article-title":"Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative","volume":"124","author":"Chaudhary","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.prp.2026.156507_bib97","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cimb43020042","article-title":"Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities","volume":"43","author":"Talib","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.prp.2026.156507_bib98","first-page":"1170","article-title":"Ketogenic diet and other dietary intervention strategies in the treatment of cancer","volume":"24","author":"Vergati","year":"2017","journal-title":"*Curr. Med. Chem. *"},{"key":"10.1016\/j.prp.2026.156507_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.634845","article-title":"The pros and cons of low carbohydrate and ketogenic diets in the prevention and treatment of cancer","volume":"8","author":"Elisia","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.prp.2026.156507_bib100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prp.2026.156507_bib101","series-title":"Study of TVB-2640 in patients with advanced solid tumors (NCT02223247)","author":"ClinicalTrials.gov","year":"2014"},{"key":"10.1016\/j.prp.2026.156507_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"A. Longenecker, First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.prp.2026.156507_bib103","series-title":"Study of TVB-2640 in men with metastatic castration-resistant prostate cancer (NCT05743621)","author":"ClinicalTrials.gov","year":"2014"},{"key":"10.1016\/j.prp.2026.156507_bib104","series-title":"A study of TVB-2640 in combination with paclitaxel and trastuzumab in HER2+ breast cancer (NCT03179904)","author":"ClinicalTrials.gov","year":"2017"},{"key":"10.1016\/j.prp.2026.156507_bib105","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II investigation of TVB-2640 (Denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156507_bib106","series-title":"A phase II study of TVB-2640 in combination with bevacizumab in recurrent high-grade astrocytoma (NCT03032484)","author":"ClinicalTrials.gov","year":"2017"},{"key":"10.1016\/j.prp.2026.156507_bib107","series-title":"TVB-2640 in patients with resectable colon cancer (NCT02980029)","author":"ClinicalTrials.gov","year":"2016"},{"key":"10.1016\/j.prp.2026.156507_bib108","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.annonc.2022.04.072","article-title":"Treatment efficacy score\u2014continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials","volume":"33","author":"Marczyk","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib109","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/or.2022.8469","article-title":"Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion","volume":"49","author":"Velez","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156507_bib110","series-title":"Specialized Programs of Research Excellence (SPORE) Grants \u2013 Hepatobiliary Clinical Trials","author":"Clinic","year":"2025"},{"key":"10.1016\/j.prp.2026.156507_bib111","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-24-2745","article-title":"SCD1 inhibition blocks the AKT-NRF2-SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma","volume":"85","author":"Sen","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156507_bib112","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells12121605","article-title":"The role of CD36 in cancer progression and its value as a therapeutic target","volume":"12","author":"Feng","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156507_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003782","article-title":"Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of \u03b2-oxidation","volume":"16","author":"Yao","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.prp.2026.156507_bib114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2026.156507_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/1120009X.2019.1694761","article-title":"Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line","volume":"32","author":"Cioccoloni","year":"2020","journal-title":"J. Chemother."},{"key":"10.1016\/j.prp.2026.156507_bib116","first-page":"345","article-title":"Orlistat as a fatty acid synthase inhibitor in cancer therapy: clinical perspectives","volume":"89","author":"Kridel","year":"2022","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.prp.2026.156507_bib117","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/cancers15153948","article-title":"Statins in cancer prevention and therapy","volume":"15","author":"Ricco","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib118","first-page":"987","article-title":"Fingolimod repurposing in oncology: sphingosine-1-phosphate modulation and tumor suppression","volume":"84","author":"Zhao","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156507_bib119","first-page":"134","article-title":"Dual targeting of fatty acid synthesis and immune checkpoints in melanoma: a preclinical study","author":"Li","year":"2023","journal-title":"Nat. Cancer 4"},{"key":"10.1016\/j.prp.2026.156507_bib120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156507_bib121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.prp.2026.156507_bib122","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jnt6030024","article-title":"Conjugate nanoparticles in cancer theranostics","volume":"6","author":"Omidian","year":"2025","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.prp.2026.156507_bib123","article-title":"Nanoparticle drug delivery systems for synergistic delivery of tumor therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156507_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925816","article-title":"Cancer therapy\u2019s impact on lipid metabolism: mechanisms and future avenues","volume":"9","author":"Bhatnagar","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.prp.2026.156507_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1464240","article-title":"Clinical implications of targeting lipid metabolism and associated pathways for cancer therapy","volume":"14","author":"Munir","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oraloncology.2018.07.001","article-title":"Salivary exosomes as potential biomarkers in cancer","volume":"84","author":"Nair","year":"2018","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib127","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/1538-7445.AM2021-568","article-title":"Nanonets for multiomics blood analysis and cancer biomarker discovery","volume":"81","author":"Gardner","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156507_bib128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer\u2014implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156507_bib129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156507_bib130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prp.2026.156507_bib131","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/pharmaceutics13060840","article-title":"Recent progress in lipid nanoparticles for cancer theranostics: opportunity and challenges","volume":"13","author":"Bukhari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156507_bib132","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/pharmaceutics16030400","article-title":"Bustanji, Liposome-based drug delivery systems in cancer research: an analysis of global landscape efforts and achievements","volume":"16","author":"Hamad","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156507_bib133","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.3390\/ijms21165845","article-title":"Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad","volume":"21","author":"Bleve","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib134","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/acsabm.2c00002","article-title":"Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review","volume":"5","author":"Khan","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.prp.2026.156507_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.972933","article-title":"Recent advances in aptamer-based targeted drug delivery systems for cancer therapy","volume":"10","author":"Gao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.prp.2026.156507_bib136","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/biology9120474","article-title":"Lipid metabolism and resistance to anticancer treatment","volume":"9","author":"Germain","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.prp.2026.156507_bib137","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41420-024-02126-9","article-title":"Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156507_bib138","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40364-024-00681-y","article-title":"Roles of posttranslational modifications in lipid metabolism and cancer progression","volume":"12","author":"Feng","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2026.156507_bib139","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.3390\/ijms21124414","article-title":"Immuno-metabolism and microenvironment in cancer: key players for immunotherapy","volume":"21","author":"Giannone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156507_bib140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-024-01981-5","article-title":"Cancer immunometabolism: advent, challenges, and perspective","volume":"23","author":"Dang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156507_bib141","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","article-title":"Immunometabolism in cancer: basic mechanisms and new targeting strategy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156507_bib142","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.3390\/cancers14205041","article-title":"Metabolomic and lipidomic profiling of gliomas\u2014A new direction in personalized therapies","volume":"14","author":"Gaca-Tabaszewska","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156507_bib143","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41467-021-27765-9","article-title":"Lipidomic profiling of human serum enables detection of pancreatic cancer","volume":"13","author":"Wolrab","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156507_bib144","first-page":"1","article-title":"Increasing inclusiveness of patient-centric clinical evidence generation in oncology: real-world data and clinical trials","volume":"42","author":"Benbow","year":"2022","journal-title":"ASCO Educ. Book"},{"issue":"68","key":"10.1016\/j.prp.2026.156507_bib145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jncimonographs\/lgae043","article-title":"Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally","author":"Monge","year":"2025","journal-title":"JNCI Monogr."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:29:24Z","timestamp":1778747364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":145,"alternative-id":["S0344033826001603"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156507","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of lipid metabolism in cancer: Mechanisms, pathways, and translational prospects","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156507"}}